Shaz BH, Winters JL, Bandarenko N, Szczepiorkowski ZM. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication. Transfusion. 2007 Nov;47(11):1963-71. (view details on MedLine)
Ashford P, Distler P, Gee A, Lankester A, Larsson S, Feller I, Loper K, Pamphilon D, Poston L, Rabe F, Slaper-Cortenbach I, Szczepiorkowski Z, Warkentin P. Terminology and labeling of cellular products: 1. Standards. Bone Marrow Transplant. 2007 Dec;40(11):1075-83. Epub 2007 Oct 1 (view details on MedLine)
Meehan KR, Wu J, Bengtson E, Hill J, Ely P, Szczepiorkowski Z, Kendall M, Ernstoff MS. Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma. Bone Marrow Transplant. 2007 Jun;39(11):695-703. Epub 2007 Apr 9 (view details on MedLine)
Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL; American Society for Apheresis; Apheresis Applications Committee of the American Society for Apheresis. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2007 Jun;22(3):106-75 (view details on MedLine)
Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 2006 Feb 2;439(7076):599-603. Epub 2005 Dec 28. (view details on MedLine)
Professional Interests:
Translational research leading to introduction of novel cellular therapies applied broadly across the field of medicine.
Evidence based approach to the use of therapeutic apheresis in clinical practice.